Development of a molecule-recognized promoter DNA sequence for inhibition of HER2 expression

Journal of Antibiotics

Volumn 62, Issue 6, 2009, Pages 339-341

  Suzuki, Tsukasa ^a   Asami, Yukihiro ^a   Takahashi, Teruyuki ^a   Wang, Xiaofei ^a   Watanabe, Takayoshi ^a   Bando, Toshikazu ^b   Sugiyama, Hiroshi ^b   Fukuda, Noboru ^a   Nagase, Hiroki ^a,c  

^a NIHON UNIVERSITY   (Japan)

^b KYOTO UNIVERSITY   (Japan)

^c ROSWELL PARK CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 2; IMIDAZOLE;

AMINO ACID SEQUENCE; ARTICLE; CELL PROLIFERATION; DNA SEQUENCE; GENETIC TRANSCRIPTION; HUMAN; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANTINEOPLASTIC AGENTS; BINDING SITES; CELL LINE, TUMOR; CELL PROLIFERATION; GENE SILENCING; HUMANS; KINETICS; NYLONS; PROMOTER REGIONS, GENETIC; RECEPTOR, ERBB-2; RNA, MESSENGER; TRANSCRIPTION FACTOR AP-2;

EID: 68149169842     PISSN: 00218820     EISSN: None     Source Type: Journal    
DOI: 10.1038/ja.2009.35     Document Type: Article

References (28)

1. Press, M. F., Cordon-Cardo, C. & Slamon, D. J. Expression of the HER-2/neu protooncogene in normal human adult and fetal tissues. Oncogene 5, 953-962 (1990).
2. Slamon, D. J. et al. Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer. Science 244, 707-712 (1989).
3. Kraus, M. H., Popescu, N. C., Amsbaugh, S. C. & King, C. R. Overexpression of the EGF receptor-related proto-oncogene erbB-2 in human mammary tumor cell lines by different molecular mechanisms. EMBO J. 6, 605-610 (1987).
4. Slamon, D. J. et al. Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene. Science 235, 177-182 (1987).
5. Gusterson, B. A. et al. Prognostic importance of c-erbB-2 expression in breast cancer. International (Ludwig) Breast Cancer Study Group. J. Clin. Oncol. 10, 1049-1056 (1992).
6. Pasleau, F., Grooteclaes, M. & Gol-Winkler, R. Expression of the c-erbB2 gene in the BT474 human mammary tumor cell line: measurement of c-erbB2 mRNA half-life. Oncogene 8, 849-854 (1993).
7. Hurst, H. C. Update on HER-2 as a target for cancer therapy: the ERBB2 promoter and its exploitation for cancer treatment. Breast Cancer Res. 3, 395-398 (2001).
8. Takahashi, I. et al. Duocarmycin A, a new antitumor antibiotic from Streptomyces. J. Antibiot. 41, 1915-1917 (1988).
9. Arcamone, F., Penco, S., Orezzi, P., Nicolella, A. & Pirelli, A. Structure and synthesis of distamycin A. Nature 203, 1064-1065 (1964).
10. Trauger, J. W., Baird, E. E. & Dervan, P. B. Extended hairpin polyamide motif for sequence-specific recognition in the minor groove of DNA. Chem. Biol. 3, 369-377 (1996).
11. Gottesfeld, J. M., Neely, L., Trauger, J. W., Baird, E. E. & Dervan, P. B. Regulation of gene expression by small molecules. Nature 387, 202-205 (1997).
12. Tao, Z. F., Fujiwara, T., Saito, I. & Sugiyama, H. Sequence-specific alkylation of DNA by duocarmycin A and its novel derivatives bearing PY/IM polyamides. Nucleosides Nucleotides 18, 1615-1616 (1999).
13. Kielkopf, C. L., Baird, E. E., Dervan, P. B. & Rees, D. C. Structural basis for G.C recognition in the DNA minor groove. Nat. Struct. Biol. 5, 104-109 (1998).
14. Dervan, P. B. Molecular recognition of DNA by small molecules. Bioorg. Med. Chem. 9, 2215-2235 (2001).
15. Dervan, P. B. & Edelson, B. S. Recognition of the DNA minor groove by pyrrole- imidazole polyamides. Curr. Opin. Struct. Biol. 13, 284-299 (2003).
16. Murty, M. S. & Sugiyama, H. Biology of N-methylpyrrole- N-methylimidazole hairpin polyamide. Biol. Pharm. Bull. 27, 468-474 (2004).
17. Zhang, W., Bando, T. & Sugiyama, H. Discrimination of hairpin polyamides with an alpha-substituted-gamma-aminobutyric acid as a 5′-TG-3′ reader in DNA minor groove. J. Am. Chem. Soc. 128, 8766-8776 (2006).
18. White, S., Baird, E. E. & Dervan, P. B. Effects of the A.T/T.A degeneracy of pyrroleimidazole polyamide recognition in the minor groove of DNA. Biochemistry 35, 12532-12537 (1996).
19. Fujimoto, K. et al. Sequence-specific protection of plasmid DNA from restriction endonuclease hydrolysis by pyrrole-imidazole- cyclopropapyrroloindole conjugates. Nucleic Acids Res. 30, 3748-3753 (2002).
20. Best, T. P., Edelson, B. S., Nickols, N. G. & Dervan, P. B. Nuclear localization of pyrrole-imidazole polyamide-fluorescein conjugates in cell culture. Proc. Natl Acad. Sci. USA 14, 12063-12068 (2003).
21. Nickols, N. G., Jacobs, C. S., Farkas, M. E. & Dervan, P. B. Improved nuclear localization of DNA-binding polyamides. Nucleic Acids Res. 35, 363-370 (2007).
22. Fukasawa, A. et al. Pharmacokinetics of pyrrole-imidazole polyamides after intravenous administration in rat. Biopharm. Drug Dispos. 30, 81-89 (2009).
23. Chiang, S. Y. et al. Targeting the Ets binding site of the HER2/neu promoter with Pyrrole-Imidazole polyamides. J. Biol. Chem. 275, 24246-24254 (2000).
24. Grooteclaes, M. et al. A new cis element is involved in the HER2 gene overexpression in human breast cancer cells. Cancer Res. 59, 2527-2531 (1999).
25. Vernimmen, D. et al. Identification of HTF (HER2 transcription factor) as an AP-2 (activator protein-2) transcription factor and contribution of the HTF binding site to ERBB2 gene overexpression. Biochem. J. 370, 323-329 (2003).
26. Bando, T., Narita, A., Saito, I. & Sugiyama, H. Molecular design of pyrrole-imidazole hairpin polyamides for effective DNA alkylation. Chemistry 8, 4781-4790 (2002).
27. Puckett, J. W. et al. Quantitative microarray profiling of DNA-binding molecules. J . Am. Chem. Soc. 129, 12310-12319 (2007).
28. Bando, T., Narita, A., Iwai, A., Kihara, K. & Sugiyama, H. C-H to N substitution dramatically alters the sequence-specific DNA alkylation, cytotoxicity, and expression of human cancer cell lines. J. Am. Chem. Soc. 126, 3406-3407 (2004).